ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing the medicines they depend on.
Our ambition is to be the partner of choice for the commercialisation of specialty, hospital, and rare disease medicines in line with our ambition, we are partnering with innovative biopharma and pharmaceutical development companies to bring medicines to patients worldwide.
Headquartered in London, UK, we have commercial sales in more than 90 countries globally and have a direct commercial presence in more than 20, including key countries in Europe, Canada, and Australia. Our Centre of Excellence in Mumbai, India, as well as an established global distribution and commercialisation partner network complement our global operations.
For decades, ADVANZ PHARMA has been committed to providing patients with a wide range of high quality and trusted specialty medicines. We cover a broad range of therapeutic areas, including hepatology, rheumatology, gastroenterology, anti-infectives, critical care, endocrinology, CNS, and, more broadly, rare diseases.
Leveraging generations of knowledge and expertise, ADVANZ PHARMA is rapidly building a diverse, long-term portfolio of biosimilars, underscoring our commitment to expanding treatment options - both now and in the future - aimed at enhancing patient care, lowering costs, and addressing the changing needs of healthcare systems.
We can only achieve our ambition with the passion of our dedicated and highly qualified people, acting in line with our company values of entrepreneurship, speed, and integrity.